Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$$ management ok
Still dripping $10 mill a quarter
The fda process is broken
The. Move along
We are trying to stop a ten thousand year old disease forever/.
Your investment will do better elsewhere..
Ema is a big step..
wasn’t on call so I didn’t hear Rett delay.
Too bad for the little girls
Who cares whether or not you are excited
what a dull post
News release gave city in USA
Propanc has a Caesar share that votes the only vote that counts
Don’t know how it’s legal but I guess if you tell people your screwing rhem before it’s ok
I have seen this before with po
Ppcb.. but that IS a scam with a Caesar share..
Under capitalized BioPharm is what it is
Understood Max
The small base of current shareholders
are NOT going to fund it’s future.
Chris is going to need a new Management team that attracts Capital..
But he bought himself time with this sale..
And Time is a precious thing..
Don’t think overhead quarterly burn very high with no Clinicals in process..
Our Neuro holding doesn’t have expense attached nor our new proposed holding..
Someone posted that all staff are now consultants..
I simply don’t know enough about reprinast..
I would turn to Neuro advantage..
Let’s find a way to make money with Neuro success..either by marketing support or equipment supply..
Let’s look at ambulatory care for stroke victims .. what will Neuro need for rapid test to determine stroke type?
What will Neuro need for immediate dosing?
It’s OUR subsidiary! Let’s use it
I also want to say..
Although this may not bring the market cap of agnpf up.. it certainly is a good start to a new trusting process
So 15,000,000 shares at 5 cents puts us at
750,000
With $2,000,000 in bank and 20% equity in ? I have no idea how big private drug co is.. but imagine they would go public or sell with ilfenprodil approval..
we would get 20% of a lot..
ilfenprodil works..I can testify
Maybe Chria can figure out a way
For algernon to partner with algernon Neuro..maybe we can have the marketing rights to DMT for North America..?
Maybe algernon can buy an emergency supplier of Mobile IV kit that algernon Neuro uses..
Now we have cash let’s create a cash flow
Thanx for the Holyday Great News!
Happy Thanksgiving!
I will have an anxious free day today!
And SLEEP great tonight..
Some Greek guy from a photoshop lab
The Invisible Hand still Loves US!
Currently more than 55 million people have dementia worldwide, over 60% of whom live in low-and middle-income countries. Every year, there are nearly 10 million new cases.
We are thinking too small
Dang it everybody
It will provide benefit to all humanity!
Put this stuff in the water!!!
They should be teaching it NOW
Apparently anavex has been tracking sleep..
Wonder if they have been tracking vision
As the ocular system is heavy with S1r
We do!
Amen!!!!
Like we aren’t the 30,000 a month for the last five years that have been diagnosed with dementia,..
Because then we would be deep in the throes of that terrible disease and not even know who we are..
How many human beings. And tragic family loved ones that have suffered that fate the edding 5 years..?
Our system is broken
The conspirators are hilarious
Drops $.40 on 200,000 shares
Goes up $.35 on 1,200,000
You don’t think it’s all rigged?
What a crock
ANAVEX®2-73 (Blarcamesine) AVATAR Phase 3 Trial met Primary and Secondary Efficacy Endpoints
Primary and all secondary efficacy and safety endpoints met for the treatment of adult patients with Rett syndrome, with consistent improvements in RSBQ AUC (p = 0.037), ADAMS (p = 0.010) and CGI-I (p = 0.037) response
Post
Jun 15
ANAVEX®2-73 Receives Compassionate Use Authorization for Pediatric Patients with Rett Syndrome
Health Canada Special Access Program (SAP) Authorizes ANAVEX®2-73 (blarcamesine) for patients after successful completion of Open-Label Extension (OLE) study
Granting of requests are also ongoing in United Kingdom and Australia – representing all regions of Rett Syndrome study participation
Post
Jun 6
Completion of ANAVEX®2-73 (blarcamesine) EXCELLENCE Phase 2/3 Rett Syndrome Clinical Trial
NEW YORK – June 6, 2023
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) disorders, today announced the completion of dosing of all participants of the placebo-controlled EXCELLENCE Phase 2/3 study ANAVEX®2-73-RS-003 in pediatric patients with Rett syndrome. The Company expects to announce topline results from this study in the second half of this year.
Second Half of THIS year
Not this time short thieves
Two things in play
One the monetixation bank has been opened
Two: your predictability means
TGD knew for any substantial change in
Market Value there would need to be at least two probably three major advancements in succession.
Rett syndrome .. is before end of year? Which is basically right now.. and as I recall .. Blarcamesine was spectacular on adult Rett syndrome we are hoping it is
Life changing for the beautiful little girls..
We are prayerful but we are also expectational of success!
Third .. the peer reviewed article
New studies for a3-71..
Partnerships for AD..
Yes the longs and others have sucked at the teet of short/sell calls long enough..
Time to start actually helping people
This will be close to the same process for fda..
Wish they would consider Argentina and Hungary as well
Remember saying Avxl would trade millions shares everyday and move multiple dollars.. just didn’t think it would be 5 years and start at $7..
What a scam the fda and Med community
Have going
Protecting death sentenced dementia patients from safe drugs,,
Thanks docs! Thanks fda!
You guys are the best!
How long do bio pros think European approval may take?”
Also when is Rett syndrome Clinicals supposed to be announced
Peer reviewed article should be getting close?
It’s been a decade and we have a platform for discovery.. they should be adding to our portfolio..
And character degradation coming from Dikcom mike is a Blessing of Encouragement
Anavex should try ..
Argentina!
Hungary
Then Israel ..
So cake and eat it too
Would like to see expanding Pharma library with development
The thought was TGD was trying to get Rett syndrome approval/Voucher first, as Alzheimer approval would void Voucher..
Does this affect the Voucher possibility
Yea.. financing can get dirty down here
Biochecker
You funny
Think they trying for Rett syndrome first for voucher
My guess is..
We still in play for Voucher for Rett Stndrime since this not fda..
Brilliant News!
Drug doc
This is a hard pill to swallow I agree..
Fda process is too expensive ..
It simply is..
Now that we know the fda will allow possible poisonous “vax” that doesn’t even stop you from getting a disease to be given to healthy babies
We know the entire process is corrupted.
Biopharma lives in a corrupted church
environment. Accept it.
Anavex dealt with Lincoln park
This is a set up for good news.
So good news is most likely coming
Truth
It’s not Missling that doesn’t underst biopharma
It’s us
We just didn’t realize how corrupt the fda system was
Nor the corruptness of the investment markets
It’s been a tough lesson
wrestling the last of my childhood joy
watching the decrepit wealthy abuse the
sick and hopeful..
Guess if I bring up anything about
experimental medicine being given to healthy pregnant women and little babies..
That’ll cross the line..
The line so many here have already crossed.. without a word
Wow what a take down..Shorts pin
the child of Down’s syndrome down to the ground for the count..
No BioPharm is worth anything these days..
AI and short selling destroy without mercy
.. good luck one and all..
The Godless rule
Another drug which Blarcamesine could act as empowering agent
Because it’s a lifelong drug..
It treats symptoms safely.. but
unfortunately deoant cure the imbalance
so .. once someone is on.. they will probably never stop ..
Phase 4 confirmatory / safety would make more sense ..after nda filed and drug aold
It’s ridiculous how expensive and lengthy clinical trials are..
We have the computational ability to
CHANGE THIS PATADIGM of death!
remember when we had drugs for cancer and pain relief?
gosh was that a decade ago already?
23.9 improvement.
No safety issues
Get the sick the drug
The fda process sucks
23.9 point improvement!
That is incredulous!
INCREDULOUS!